Details for New Drug Application (NDA): 216021
✉ Email this page to a colleague
The generic ingredient in PANTOPRAZOLE SODIUM is pantoprazole sodium. There are forty-eight drug master file entries for this compound. Seventy-one suppliers are listed for this compound. Additional details are available on the pantoprazole sodium profile page.
Summary for 216021
Tradename: | PANTOPRAZOLE SODIUM |
Applicant: | Fresenius Kabi Usa |
Ingredient: | pantoprazole sodium |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 40MG BASE/VIAL | ||||
Approval Date: | Aug 1, 2024 | TE: | AP | RLD: | No |
Complete Access Available with Subscription